InvestorsHub Logo
icon url

rf101459

09/19/20 11:26 AM

#12041 RE: mrfumbles #12039

I get the feeling RVVTF Bucillamine is still under the radar but that could change very quickly. My daughter is a nurse and asked a doctor a question about Bucillamine which the docter found it to be very interesting after looking into it. But never heard about it till mentioned.
icon url

Full Contact Yoga

09/19/20 11:54 AM

#12044 RE: mrfumbles #12039

Not Apples to Apples...the other is super legit and deeply funded by power brokers with pull, plus they own and created the synthetic version, which will generate endless income if it comes to fruition. this, at the end of the day is still just a pink sheet stock hoping to do something soon...bucilamine is cool, but it has an end date to some extent, no longer needed with viable vaccines. Perhaps other uses though. Pretty old drug, re-purposing could have many paths...as for the shrooms here, interesting study, but not really unique, time will tell.
icon url

RioDad

09/19/20 11:28 PM

#12063 RE: mrfumbles #12039

The IPO company is ahead of RVVTF in the shroom testing.

Life isn’t fair, but Revive is a winner.